Author:
Ahn Hee Kyung,Jung Minkyu,Ha Seung-Yeon,Lee Jae-Ik,Park Inkeun,Kim Young Saing,Hong Junshik,Sym Sun Jin,Park Jinny,Shin Dong Bok,Lee Jae Hoon,Cho Eun Kyung
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133(4):1710–5.
2. Sofocleous CT, Garg SK, Cohen P, Petre EN, Gonen M, Erinjeri JP, et al. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation. Ann Surg Oncol. 2013. doi: 10.1245/s10434-013-3140-1 .
3. Jakobsen JN, Sorensen JB. Clinical impact of ki-67 labeling index in non-small cell lung cancer. Lung Cancer. 2013;79(1):1–7. doi: 10.1016/j.lungcan.2012.10.008 .
4. Salgia R, Skarin AT. Molecular abnormalities in lung cancer. J Clin Oncol. 1998;16(3):1207–17.
5. Hall PA, Ray A, Lemoine NR, Midgley CA, Krausz T, Lane DP. p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet. 1991;338(8765):513.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献